You did it to yourself.” This is one of the things that patients who are diagnosed with COPD often hear because of the stigma ...

Please provide your email address to receive an email when new articles are posted on . Pulmonary hypertension appears in 25% to 30% of patients with COPD. There are no approved therapies for patients ...

Patients with COPD and coexisting OSAS have greater impairments in muscle quality and physical performance than those with isolated COPD.

Escalating to extrafine single-inhaler triple therapy significantly reduces exacerbations in patients with moderate to severe COPD.

Jeffrey D. Dunn, PharmD, MBA, leads a panel discussion on disease and treatment landscapes for COPD. Jeffrey D. Dunn, PharmD, MBA: Hello, and welcome to this AJMC® program titled “Medication ...

Patients with COPD and heart failure treated with SGLT-2 inhibitors experienced higher rates of volume depletion and adverse renal events. Chronic obstructive pulmonary disease (COPD) reduces the ...

Chronic lower respiratory diseases, namely, asthma and chronic obstructive pulmonary disease (COPD), are the fifth-leading cause of death in the United States. A contributing factor is diagnostic ...

Chronic obstructive pulmonary disease (COPD) is known for causing breathing difficulties and limiting everyday activities.

US patients with chronic obstructive pulmonary disease (COPD) managed in primary care settings have high exacerbations, symptoms, and treatment burdens, according to an analysis of electronic health ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. When a patient made a ...

The study will enrol 160 patients with IPF who have not previously received treatment.